1. Home
  2. LNTH vs CPK Comparison

LNTH vs CPK Comparison

Compare LNTH & CPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNTH
  • CPK
  • Stock Information
  • Founded
  • LNTH 1956
  • CPK 1990
  • Country
  • LNTH United States
  • CPK United States
  • Employees
  • LNTH N/A
  • CPK N/A
  • Industry
  • LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • CPK Oil & Gas Production
  • Sector
  • LNTH Health Care
  • CPK Utilities
  • Exchange
  • LNTH Nasdaq
  • CPK Nasdaq
  • Market Cap
  • LNTH 3.6B
  • CPK 2.9B
  • IPO Year
  • LNTH 2015
  • CPK N/A
  • Fundamental
  • Price
  • LNTH $58.21
  • CPK $127.42
  • Analyst Decision
  • LNTH Strong Buy
  • CPK Hold
  • Analyst Count
  • LNTH 6
  • CPK 2
  • Target Price
  • LNTH $105.50
  • CPK $124.50
  • AVG Volume (30 Days)
  • LNTH 2.5M
  • CPK 101.2K
  • Earning Date
  • LNTH 08-06-2025
  • CPK 08-07-2025
  • Dividend Yield
  • LNTH N/A
  • CPK 2.17%
  • EPS Growth
  • LNTH N/A
  • CPK 16.73
  • EPS
  • LNTH 3.77
  • CPK 5.60
  • Revenue
  • LNTH $1,520,653,000.00
  • CPK $866,700,000.00
  • Revenue This Year
  • LNTH $4.57
  • CPK $14.68
  • Revenue Next Year
  • LNTH $9.41
  • CPK $3.50
  • P/E Ratio
  • LNTH $15.42
  • CPK $22.59
  • Revenue Growth
  • LNTH 5.75
  • CPK 18.91
  • 52 Week Low
  • LNTH $47.25
  • CPK $112.92
  • 52 Week High
  • LNTH $118.21
  • CPK $136.73
  • Technical
  • Relative Strength Index (RSI)
  • LNTH 40.12
  • CPK 66.68
  • Support Level
  • LNTH $55.00
  • CPK $123.63
  • Resistance Level
  • LNTH $56.16
  • CPK $126.05
  • Average True Range (ATR)
  • LNTH 2.52
  • CPK 2.04
  • MACD
  • LNTH 0.57
  • CPK 0.39
  • Stochastic Oscillator
  • LNTH 41.41
  • CPK 96.67

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

About CPK Chesapeake Utilities Corporation

Chesapeake Utilities Corp is a diversified energy delivery company that is engaged in natural gas transmission and distribution, electricity generation and distribution, propane gas distribution, mobile compressed natural gas utility services and solutions and other businesses. The company operates in two reportable segments, Regulated Energy and Unregulated Energy. The company's natural gas and electric distribution operations in Delaware, Maryland and Florida are subject to regulation by PSC. Eastern Shore, its natural gas transmission is subject to regulation by the FERC and Peninsula Pipeline and Aspire Energy Express, its intrastate pipeline subsidiaries, are subject to regulation by the Florida PSC and Public Utilities Commission of Ohio, respectively.

Share on Social Networks: